Role of Gait Analysis in Different Type of Dementia
Pattern of Gait Abnormality As a Predictor for Disease Progression in Dementia
1 other identifier
observational
102
0 countries
N/A
Brief Summary
Aim for the work is the studying of the existence and pattern of gait impairment in pre-dementia and dementia To examine the association between dual decline in gait and cognition
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedFirst Posted
Study publicly available on registry
December 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedDecember 3, 2024
October 1, 2024
5 months
June 2, 2024
November 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analysis and comparison gait analysis in different types of dementia , pre dementia and elderly people
\- The studying of the existence and pattern of gait impairment in pre-dementia and dementia and Role and important gait in prediction of disease progression by * The new smart insole PODOSmart®, a new tool for gait analysis recording the gait through sensors in foot tabs for 60 seconds and analysing the data. * Advanced athactivity of daily living scale (AADLs). * Berg balance test (BBT) . Other tools for gait analysis: Dynamic gait index and Figure 8 walk test So, this will study the association between dual decline in gait and cognition with the risk of dementia. And studying of relationship between gait impairment and Cognitive decline in Dementic patients ,which the greater cognitive decline,the greater gait impairment.
Baseline
Study Arms (1)
Cohort 1 (Dementia)
The group that will contain the diseased participants (Dementic patients able to walk and perform gait analysis)
Eligibility Criteria
Patients aged 30 to 80 yrs old diagnosed with pre-dementia and/or dementia according to the Vascular Behavior and Cognitive Disorder (VASCOG) who are able to perform gait analysis tests
You may qualify if:
- patients with pre-dementia,dementia, and dementia diagnosed according to The Vascular Behaviour and Cognitive Disorder (VASCOG) and on medication Criteria attending Assiut University neurology outpatient clinic and internal department
You may not qualify if:
- history of clinic manfist cerebrovascular stroke 2 definitely laterization sign 3 severe cognitive imparment MOCA 4 Spinal or orthopaedic problems 5 long-term use or abuse of medication affect cognition or balance 6 clinical evidence of peripheral neuropathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (17)
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimaki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30. No abstract available.
PMID: 32738937BACKGROUNDJack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0.
PMID: 23332364BACKGROUNDBorson S, Raskind MA. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology. 1997 May;48(5 Suppl 6):S17-24. doi: 10.1212/wnl.48.5_suppl_6.17s.
PMID: 9153156BACKGROUNDRodriguez Garcia PL, Rodriguez Garcia D. Diagnosis of vascular cognitive impairment and its main categories. Neurologia. 2015 May;30(4):223-39. doi: 10.1016/j.nrl.2011.12.014. Epub 2012 Jun 26. English, Spanish.
PMID: 22739039BACKGROUNDDicharry J. Kinematics and kinetics of gait: from lab to clinic. Clin Sports Med. 2010 Jul;29(3):347-64. doi: 10.1016/j.csm.2010.03.013.
PMID: 20610026BACKGROUNDJayakody O, Breslin M, Srikanth VK, Callisaya ML. Gait Characteristics and Cognitive Decline: A Longitudinal Population-Based Study. J Alzheimers Dis. 2019;71(s1):S5-S14. doi: 10.3233/JAD-181157.
PMID: 30958358BACKGROUNDVerghese J, Wang C, Lipton RB, Holtzer R, Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):929-35. doi: 10.1136/jnnp.2006.106914. Epub 2007 Jan 19.
PMID: 17237140BACKGROUNDMoran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V; Alzheimer's Disease Neuroimaging Initiative (ADNI). Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology. 2015 Sep 29;85(13):1123-30. doi: 10.1212/WNL.0000000000001982. Epub 2015 Sep 2.
PMID: 26333802BACKGROUNDBrach JS, Talkowski JB, Strotmeyer ES, Newman AB. Diabetes mellitus and gait dysfunction: possible explanatory factors. Phys Ther. 2008 Nov;88(11):1365-74. doi: 10.2522/ptj.20080016. Epub 2008 Sep 18.
PMID: 18801861BACKGROUNDBlumen HM, Brown LL, Habeck C, Allali G, Ayers E, Beauchet O, Callisaya M, Lipton RB, Mathuranath PS, Phan TG, Pradeep Kumar VG, Srikanth V, Verghese J. Gray matter volume covariance patterns associated with gait speed in older adults: a multi-cohort MRI study. Brain Imaging Behav. 2019 Apr;13(2):446-460. doi: 10.1007/s11682-018-9871-7.
PMID: 29629501BACKGROUNDJayakody O, Breslin M, Beare R, Srikanth VK, Blumen HM, Callisaya ML. The Associations Between Grey Matter Volume Covariance Patterns and Gait Variability-The Tasmanian Study of Cognition and Gait. Brain Topogr. 2021 Jul;34(4):478-488. doi: 10.1007/s10548-021-00841-5. Epub 2021 Apr 29.
PMID: 33914190BACKGROUNDRosano C, Studenski SA, Aizenstein HJ, Boudreau RM, Longstreth WT Jr, Newman AB. Slower gait, slower information processing and smaller prefrontal area in older adults. Age Ageing. 2012 Jan;41(1):58-64. doi: 10.1093/ageing/afr113. Epub 2011 Sep 28.
PMID: 21965414BACKGROUNDSrikanth V, Beare R, Blizzard L, Phan T, Stapleton J, Chen J, Callisaya M, Martin K, Reutens D. Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study. Stroke. 2009 Jan;40(1):175-80. doi: 10.1161/STROKEAHA.108.524355. Epub 2008 Oct 16.
PMID: 18927448BACKGROUNDDel Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, Cesari M, Weiner MW, Andrieu S, Vellas B; MAPT/DSA Study Group. Relationship of regional brain beta-amyloid to gait speed. Neurology. 2016 Jan 5;86(1):36-43. doi: 10.1212/WNL.0000000000002235. Epub 2015 Dec 7.
PMID: 26643548BACKGROUNDDias EN, da Silva JV, Pais-Ribeiro JL, Martins T. Validation of the advanced activities of daily living scale. Geriatr Nurs. 2019 Jan-Feb;40(1):7-12. doi: 10.1016/j.gerinurse.2018.05.008. Epub 2018 Jun 13.
PMID: 29909023BACKGROUNDRahman TT, El Gaafary MM. Montreal Cognitive Assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatr Gerontol Int. 2009 Mar;9(1):54-61. doi: 10.1111/j.1447-0594.2008.00509.x.
PMID: 19260980BACKGROUNDBerg KO, Wood-Dauphinee SL, Williams JI, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health. 1992 Jul-Aug;83 Suppl 2:S7-11.
PMID: 1468055BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anwer M Ali, Professor
Department of Neuropsychiatry in Assuit University Tertiary Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
June 2, 2024
First Posted
December 3, 2024
Study Start
December 1, 2024
Primary Completion
May 1, 2025
Study Completion
October 1, 2025
Last Updated
December 3, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share